Wednesday, January 3, 2018

Statement from FDA Commissioner Scott Gottlieb, MD on new steps ...

FDA.gov-7 hours ago
The FDA today announced additional steps to encourage generic competition as part of our continued implementation of the Drug Competition Action Plan. This plan has three main components: reducing gaming by branded companies that can delay generic drug entry; resolving scientific and regulatory obstacles that can ...
Post a Comment